| 24 May 2026 |
DHB (1-Test Cyp) Oral |
4.6 |
100mg |
110.0mg |
+10.0% |
98.00% |
Lab G |
| 24 May 2026 |
Selank |
5.5 |
5mg |
4.4mg |
-12.8% |
96.73% |
Lab E |
| 24 May 2026 |
Clomiphene (Clomid) Raw |
6.4 |
5g |
4.5g |
-10.1% |
96.31% |
Lab G |
| 24 May 2026 |
Retatrutide 30mg Pen Kit |
9.3 |
10mg |
9.2mg |
-8.3% |
96.26% |
Lab B |
| 24 May 2026 |
EPO |
7.1 |
20mg |
18.9mg |
-5.3% |
96.29% |
Lab G |
| 23 May 2026 |
Tirzepatide |
10.0 |
30mg |
31.3mg |
+4.3% |
99.88% |
Lab E |
| 23 May 2026 |
Semaglutide Oral |
8.4 |
100mg |
112.2mg |
+12.2% |
99.04% |
Lab C |
| 23 May 2026 |
Tren Hex |
6.3 |
300mg/ml |
268.9mg/ml |
-10.4% |
97.32% |
Lab E |
| 21 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.9 |
10mg |
11.6mg |
+16.1% |
97.45% |
Lab A |
| 21 May 2026 |
Andarine S4 |
7.0 |
25mg |
30.5mg |
+21.9% |
96.48% |
Lab B |
| 20 May 2026 |
Blend 300 (TRA/Mast P/Test P) |
8.3 |
250mg/ml |
287.1mg/ml |
+14.8% |
97.34% |
Lab D |
| 19 May 2026 |
Test Suspension |
5.5 |
300mg/ml |
357.9mg/ml |
+19.3% |
95.87% |
Lab B |
| 17 May 2026 |
Adipotide |
10.0 |
50mg |
46.9mg |
-6.2% |
95.45% |
Lab E |
| 17 May 2026 |
Tamoxifen (Nolvadex) |
8.5 |
20mg |
22.1mg |
+10.6% |
99.17% |
Lab C |
| 26 Jan 2026 |
BPC157 5mg + TB500 5mg Blend |
8.4 |
50mg |
51.7mg |
+3.5% |
98.20% |
Lab E |
| 26 Jan 2026 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
5.8 |
10mg |
10.9mg |
+9.4% |
99.91% |
Lab A |
| 9 Jan 2026 |
Bronchogen |
4.0 |
2mg |
2.3mg |
+15.8% |
96.43% |
Lab B |
| 7 Jan 2026 |
Anadrol Oil |
8.3 |
300mg/ml |
323.0mg/ml |
+7.7% |
96.33% |
Lab E |
| 6 Jan 2026 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
10.0 |
2mg |
2.3mg |
+13.0% |
97.22% |
Lab F |
| 6 Jan 2026 |
Pinealon |
4.6 |
50mg |
55.5mg |
+11.0% |
95.14% |
Lab E |
| 29 Dec 2025 |
1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 |
6.7 |
500g |
621.1g |
+24.2% |
98.86% |
Lab A |
| 29 Dec 2025 |
MOTS-C |
7.0 |
5mg |
5.4mg |
+8.0% |
96.42% |
Lab A |
| 17 Dec 2025 |
Tirzepatide |
9.4 |
10mg |
9.32mg |
-6.8% |
99.95% |
Lab E |
| 17 Nov 2025 |
CJC-1295 With DAC |
7.5 |
30mg |
28.5mg |
-5.0% |
96.08% |
Lab E |
| 14 Nov 2025 |
Vesugen |
7.9 |
10mg |
12.5mg |
+24.9% |
96.15% |
Lab A |
| 5 Nov 2025 |
Cartalax |
6.3 |
5mg |
4.9mg |
-2.3% |
99.24% |
Lab F |
| 5 Nov 2025 |
TriTren 225 |
6.9 |
250mg/ml |
250.7mg/ml |
+0.3% |
98.25% |
Lab F |
| 4 Nov 2025 |
Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) |
4.0 |
250mg/ml |
288.5mg/ml |
+15.4% |
98.22% |
Lab D |
| 4 Nov 2025 |
MGF |
7.9 |
10mg |
9.0mg |
-10.4% |
99.56% |
Lab A |
| 9 Oct 2025 |
APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 |
7.4 |
5g |
6.0g |
+20.7% |
98.83% |
Lab B |
| 9 Oct 2025 |
Botulinum toxin |
9.6 |
2mg |
2.1mg |
+4.4% |
96.59% |
Lab C |
| 9 Oct 2025 |
P21 |
8.9 |
2mg |
1.9mg |
-2.5% |
95.97% |
Lab A |
| 9 Oct 2025 |
Selank 10mg + Semax 10mg Blend |
7.6 |
2mg |
2.0mg |
-0.2% |
95.24% |
Lab A |
| 3 Oct 2025 |
Minoxidil Oral |
6.5 |
50mg |
60.1mg |
+20.2% |
98.00% |
Lab A |
| 3 Oct 2025 |
PTD-DBM |
9.3 |
5mg |
5.6mg |
+11.4% |
96.36% |
Lab F |
| 28 Aug 2025 |
Tirzepatide |
8.0 |
30mg |
29.3mg |
-2.3% |
99.88% |
Lab E |
| 28 Aug 2025 |
Tirzepatide |
8.0 |
30mg |
29.2mg |
-2.7% |
99.89% |
Lab E |
| 5 Aug 2025 |
Tirzepatide |
4.4 |
20mg |
16.9mg |
-15.5% |
86.05% |
Lab E |
| 5 Aug 2025 |
Tirzepatide |
6.1 |
20mg |
18.5mg |
-7.5% |
92.03% |
Lab E |